PO

Precision Optics Corporation, Inc.

POCIHealthcareNASDAQ

Medical Instruments & Supplies

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$31.5M
+65.2% YoY
Net Income
-$3.6M
+37.2% YoY
EBITDA
-$3.2M
+40.1% YoY
Free Cash Flow
-$853,414

Scan Results

Daily timeframe
DateIndicatorDetails
Oct 20▼ MACD Negative CrossoverHistogram -0.0274, negative momentum
Oct 19▼ MACD Negative CrossoverHistogram -0.0192, negative momentum
About Precision Optics Corporation, Inc.

Headquartered within the healthcare sector, Precision Optics Corporation, Inc. focuses on Medical Instruments & Supplies services and products. Precision Optics Corporation, Inc. The company carries a $47.5M market cap, placing it firmly in the micro-cap category. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

Where POCI stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, POCI finished 7.38% below its 150-day moving average ($4.61) and 7.58% below its 200-day moving average ($4.62). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is POCI overbought or oversold?

At the October 20, 2026 close, POCI's RSI(14) was 50.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$47.5M
Fwd P/E144.33
EPS$-0.43
Beta0.34
52W Change+0.7%
Dividend Yield0.00%
ROE-22.3%
Analysis

With $9.8M in cash and $4.1M in debt, POCI maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$853K, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -22.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been uneven over recent years, ranging from $21.0M to $31.5M.

POCI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Precision Optics Corporation, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms